Evidence map›Paper›PMID 27614711›Full record

ReviewCurrent opinion in microbiology2016

Exploiting the Achilles' heel of membrane trafficking in trypanosomes.

Martin Zoltner, David Horn, Harry P de Koning, Mark C Field

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.International journal for parasitology. Drugs and drug resistance · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Drug resistance in protozoan parasites.Emerging topics in life sciences · 2017
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Martin ZoltnerSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK.
David HornSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK.
Harry P de KoningInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, Scotland, UK.
Mark C FieldSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK. Electronic address: mfield@mac.com.

Funding

Medical Research Council MR/K000500/1Medical Research Council MR/K008749/1Medical Research Council MR/L018853/1Wellcome TrustWellcome Trust 100320/Z/12/ZWellcome Trust 105021/Z/14/Z
6 · The paper itself

Abstract

Pathogenic protozoa are evolutionarily highly divergent from their metazoan hosts, reflected in many aspects of their biology. One particularly important parasite taxon is the trypanosomatids. Multiple transmission modes, distinct life cycles and exploitation of many host species attests to great prowess as parasites, and adaptability for efficient, chronic infection. Genome sequencing has begun uncovering how trypanosomatids are well suited to parasitism, and recent genetic screening and cell biology are revealing new aspects of how to control these organisms and prevent disease. Importantly, several lines of evidence suggest that membrane transport processes are central for the sensitivity towards several frontline drugs.

Indexed as

AnimalsBiological EvolutionBiological TransportCell MembraneHost-Parasite InteractionsHumansLife Cycle StagesMembrane Transport ProteinsProtein TransportProtozoan ProteinsTrypanocidal AgentsTrypanosoma brucei bruceiTrypanosomiasisMembrane Transport ProteinsProtozoan ProteinsTrypanocidal Agents

Identifiers

PMID27614711
PMCPMC5176092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.